Longitudinally extensive transverse myelitis: A catastrophic presentation of a flare-up of systemic lupus erythematosus

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 3, 2012, Pages

  White, Colin ^a   Leonard, Blair ^a   Patel, Ameen ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; AREFLEXIA; ARTHRALGIA; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG PULSE THERAPY; FATIGUE; FECES INCONTINENCE; FEVER; HUMAN; LABORATORY TEST; LOW BACK PAIN; MAINTENANCE THERAPY; MALAISE; MALE; MYALGIA; MYELITIS; NEPHRITIS; NOSE ULCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHYSIOTHERAPY; PLASMAPHERESIS; RASH; REMISSION; RIGOR; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE RETENTION;

EID: 84857408785     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.101213     Document Type: Article

References (15)

1. Kovacs B, Lafferty TL, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4. (Pubitemid 30305609)
2. Espinosa G, Mendizábal A, Mínguez S, et al. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 2010; 39: 246-56.
3. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9. (Pubitemid 43958540)
4. Dolhun R, Sriram S. Neurosarcoidosis presenting as longitudinally extensive transverse myelitis. J Clin Neurosci 2009; 16: 595-7.
5. Vinken PJ, Bruyn GW, Klawans HL, editors. Nervous system involvement in systemic lupus erythematosus including the antiphospholid antibody syndrome. In: Handbook of Clinical Neurology. Vol. 27(71): systemic disease part III. Amsterdam: Elsevier Science B.V.; 1998. p. 35-58.
6. Merine D, Wang H, Kumar AJ, et al. CT myelopathy and MRI imaging of acute transverse myelitis. J Comput Tomogr 1987; 11: 606-8. (Pubitemid 17104760)
7. Brinar VV, Habek M, Zadro I, et al. Current concepts in the diagnosis of transverse myelopathies. Clin Neurol Neurosurg 2008; 110:919-27.
8. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol 1999;26:446-9. (Pubitemid 29066754)
9. Kaplin AI, Krishnan C, Deshpande DM, et al. Diagnosis and management of acute myelopathies. Neurologist 2005;11:2-18. (Pubitemid 40111067)
10. D'Cruz DP, Mellor-Pita S, Joven B, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupuslike disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004;31:280-5. (Pubitemid 38160749)
11. Katsiari CG, Giavri I, Mitsikostas DD, et al. Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation. Eur J Neurol 2011;18:556-63.
12. Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
13. Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978;4:51-9. (Pubitemid 8378202)
14. Téllez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, et al. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 2001;10:851-6. (Pubitemid 34019215)
15. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010;69:2074-82.